Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Notes Payables: 2014-2024

Historic Notes Payables for Aytu Biopharma (AYTU) over the last 6 years, with Jun 2024 value amounting to $2.4 million.

  • Aytu Biopharma's Notes Payables rose 291.03% to $4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.0 million, marking a year-over-year increase of 291.03%. This contributed to the annual value of $2.4 million for FY2024, which is 53.23% up from last year.
  • As of FY2024, Aytu Biopharma's Notes Payables stood at $2.4 million, which was up 53.23% from $1.6 million recorded in FY2023.
  • Over the past 5 years, Aytu Biopharma's Notes Payables peaked at $3.8 million during FY2022, and registered a low of $982,076 during FY2020.
  • Moreover, its 3-year median value for Notes Payables was $2.4 million (2024), whereas its average is $2.6 million.
  • Per our database at Business Quant, Aytu Biopharma's Notes Payables tumbled by 59.01% in 2023 and then skyrocketed by 53.23% in 2024.
  • Yearly analysis of 4 years shows Aytu Biopharma's Notes Payables stood at $982,076 in 2020, then reached $3.8 million in 2022, then crashed by 59.01% to $1.6 million in 2023, then soared by 53.23% to $2.4 million in 2024.